These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34089721)

  • 1. Polygenic Risk Scores Stratify Keratinocyte Cancer Risk among Solid Organ Transplant Recipients with Chronic Immunosuppression in a High Ultraviolet Radiation Environment.
    Seviiri M; Law MH; Ong JS; Gharahkhani P; Nyholt DR; Hopkins P; Chambers D; Campbell S; Isbel NM; Soyer HP; Olsen CM; Ellis JJ; Whiteman DC; Green AC; MacGregor S
    J Invest Dermatol; 2021 Dec; 141(12):2866-2875.e2. PubMed ID: 34089721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic Risk Scores Allow Risk Stratification for Keratinocyte Cancer in Organ-Transplant Recipients.
    Seviiri M; Law MH; Ong JS; Gharahkhani P; Nyholt DR; Olsen CM; Whiteman DC; MacGregor S
    J Invest Dermatol; 2021 Feb; 141(2):325-333.e6. PubMed ID: 32615124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin Cancer Development Is Strongly Associated with Actinic Keratosis in Solid Organ Transplant Recipients: A Danish Cohort Study.
    Wenande E; Togsverd-Bo K; Hastrup A; Lei U; Philipsen PA; Haedersdal M
    Dermatology; 2023; 239(3):393-402. PubMed ID: 36731451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
    Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
    Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.
    Zamoiski RD; Yanik E; Gibson TM; Cahoon EK; Madeleine MM; Lynch CF; Gustafson S; Goodman MT; Skeans M; Israni AK; Engels EA; Morton LM
    Cancer Res; 2017 Aug; 77(15):4196-4203. PubMed ID: 28615224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
    Neuberger A; Menzer C; Volk N; Enk AH; Hadaschik EN; Lonsdorf AS
    Eur J Dermatol; 2021 Oct; 31(5):609-615. PubMed ID: 34903507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
    Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
    JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
    Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
    J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients.
    Herman S; Rogers HD; Ratner D
    Skinmed; 2007; 6(5):234-8. PubMed ID: 17786101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capecitabine for skin cancer prevention in solid organ transplant recipients.
    Jirakulaporn T; Endrizzi B; Lindgren B; Mathew J; Lee PK; Dudek AZ
    Clin Transplant; 2011; 25(4):541-8. PubMed ID: 21050273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Life UV and Risk of Basal and Squamous Cell Carcinoma in New South Wales, Australia.
    Kricker A; Weber M; Sitas F; Banks E; Rahman B; Goumas C; Kabir A; Hodgkinson VS; van Kemenade CH; Waterboer T; Armstrong BK
    Photochem Photobiol; 2017 Nov; 93(6):1483-1491. PubMed ID: 28710897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
    Cheng JY; Li FY; Ko CJ; Colegio OR
    JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for ultraviolet radiation immunosuppression in non-melanoma skin cancer as evidenced by gene-environment interactions.
    Welsh MM; Karagas MR; Applebaum KM; Spencer SK; Perry AE; Nelson HH
    Carcinogenesis; 2008 Oct; 29(10):1950-4. PubMed ID: 18641401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
    Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
    Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative ultraviolet radiation flux in adulthood and risk of incident skin cancers in women.
    Wu S; Han J; Vleugels RA; Puett R; Laden F; Hunter DJ; Qureshi AA
    Br J Cancer; 2014 Apr; 110(7):1855-61. PubMed ID: 24595003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Rare Cancers Among Solid Organ Transplant Recipients.
    D'Arcy ME; Castenson D; Lynch CF; Kahn AR; Morton LM; Shiels MS; Pfeiffer RM; Engels EA
    J Natl Cancer Inst; 2021 Feb; 113(2):199-207. PubMed ID: 32462187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin and gut microbial associations with squamous cell carcinoma in solid organ transplant recipients.
    Ha MV; McCormick TS; Salem I; Al-Shakhshir H; Ghannoum MA; Carroll BT
    Arch Dermatol Res; 2023 Nov; 315(9):2709-2713. PubMed ID: 37278910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
    Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL
    N Engl J Med; 2023 Mar; 388(9):804-812. PubMed ID: 36856616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Dose Acitretin for Secondary Prevention of Keratinocyte Carcinomas in Solid-Organ Transplant Recipients.
    Solomon-Cohen E; Reiss-Huss S; Hodak E; Davidovici B
    Dermatology; 2022; 238(1):161-166. PubMed ID: 33902035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.